Table 1.
1. | Squamous cell histology |
2. | High burden of disease-related symptoms, which might be relieved by tumour response |
3. | Pre-existing neuropathy or at risk for the development of neuropathy |
4. | Elderly |
5. | Pre-existing diabetes or prediabetic state |
6. | Comorbid mild or moderate renal dysfunction |
nab-PC, nab-paclitaxel/carboplatin; NSCLC, non-small cell lung cancer.